Postmenopausal women with GST polymorphisms leading to low or no GSTT1, GSTP1 and GSTM1 activity benefitted to a greater extent from the consumption of marine ω3 fatty acids in the context of breast cancer [51]. Here, GSTM1 is linked to breast cancer.